Safety-Related Labeling Changes
Warnings related to benzoic acid, addition of sodium content, anticoagulant-related nephropathy,
Trade Name
Solfarin
Updated Section
4.4 Special warnings and precautions for use. 4.8 Undesirable effects
Month
Nov,2024